Catal­ent keeps adding on at key Ital­ian plant, this time with a pair of new biore­ac­tors and 100 jobs

For the sec­ond time in less than six months, Catal­ent will up­grade its sleek new fa­cil­i­ty in Anag­ni, Italy, this time to add bi­o­log­ics drug sub­stance man­u­fac­tur­ing ca­pa­bil­i­ties to sup­port an in­crease in de­mand.

Two new 2,000 liter sin­gle-use biore­ac­tors with new man­u­fac­tur­ing suites will sup­port ear­ly-phase clin­i­cal de­vel­op­ment and late-stage com­mer­cial trans­fers, the com­pa­ny said in a press re­lease, as well as space for an­oth­er six biore­ac­tors to be added in the fu­ture. The project is ex­pect­ed to add 100 new em­ploy­ees, and it should be op­er­a­tional in April 2023.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER